Headlines

PRE-MARKET AUSTRALIAN STOCKS NEWS: Challenger (CGF AT) rejected Daiichi Life's improved AUD 5.59bln takeover offer

Newsquawk Staff ·

Challenger (CGF AT) - Co. rejected Daiichi Life's improved AUD 5.59bln takeover offer of AUD 12.20/shr for the remaining 79.5% stake, stating that the revised proposal does not represent fair value. (Dow Jones Newswires)

Dexus (DXS AT) - Co. is reportedly seeking to raise AUD 500mln for its balance sheet by offering investors stakes in six landmark office towers valued at AUD 3.75bln through a new club fund, amid a sluggish office market and ongoing legal disputes with superannuation funds. (The Australian)

Fortescue (FMG AT) - Nicola Forrest reportedly wrote to the Co.'s board demanding it take allegations of bullying and harassment seriously, invoking her position as an influential shareholder. (The Australian)

Nufarm (NUF AT) - Co. FY (AUD) net loss 79.5mln, net profit before material items 19.9mln, underlying EBITDA rose 25% Y/Y to 378.3mln, rev. fell 6.8% Y/Y to 3.21bln, no final dividend. (Dow Jones Newsplus)

Regis Resources (RRL AT) - Co. remains some time away from a new decision on its McPhillamys project while advancing a dual-track strategy, and remains open to acquisition opportunities but faces no pressure to pursue deals given its strong growth pipeline, according to Chair James Mactier. (Dow Jones Newswires)

Sunrise Energy Metals (SRL AT) - Co. received Foreign Investment Review Board approval to redomicile from Australia to the US, with implementation expected in late January. (Dow Jones Newswires)

Transurban (TCL AT) - Co. October average daily traffic rose 0.7% Y/Y. (Dow Jones Newswires)

Worley (WOR AT) - Co. reaffirmed FY27 revenue and EBITA guidance, with overall activity progressing in line with its August outlook despite continued disruption and softness, while seeing considerable activity across the US and Canada and expecting increased Middle East work volumes over the medium term; Co. also acknowledged concerns over restructuring cost treatment, committed to transparent financial disclosure and commenced a search for a new Chair, with Deputy Chair Andrew Liveris ruled out as a candidate. (Dow Jones Newswires)

Zip (ZIP AT) - Co. maintained FY27 revenue, margin and earnings guidance. (Dow Jones Newswires)

Broker Ratings/Price Target

  • Ramsay Health Care (RHC AT) price target raised 13% to AUD 55.50/shr by Citi.

What it means

The lead item is a target board rejecting a sweetened bid as undervaluing the company, a familiar staging point in Australian takeover practice where boards rarely accept a first or even second approach and the rejection itself is often the opening of price discovery rather than the end of the process. The structure here matters: the bidder already holds a minority stake and is chasing the remainder, which historically gives the incumbent strategic leverage but also constrains competing bidders, so the next tells are whether the bidder returns with a further bump, goes hostile via direct appeal to shareholders, or walks, and whether the target's fair value argument is backed by an independent expert's report. Rejection of an improved offer has tended to leave the target's shares trading on both the rejected level and the prospect of more, with the rejected price acting as a soft floor in comparable episodes. Elsewhere in the summary, the mix is routine pre-market fare: a capital raise against a weak office market, reaffirmed guidance, an FIRB-approved redomicile, and modest traffic data, none of which individually rewrites a thesis but which together sketch the familiar Australian session pattern of financials and property carrying the news flow. Worth noting is the governance strand running through several items, shareholder activism at one miner and a chair search at an engineer, which in past cycles has preceded board and strategic change rather than resolved it.

Related headlines